Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson's Disease, Both In Vivo and In Vitro.

Saved in:
Bibliographic Details
Title: Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson's Disease, Both In Vivo and In Vitro.
Authors: Guclu E; Department of Basic Sciences and Health, Hemp Research Institute, University of Yozgat Bozok, Yozgat, Turkey., Inan SY; Department of Medical Pharmacology, Faculty of Medicine, University of Konya-NE, Akyokus, 42080, Meram, Konya, Turkey. salim.inan@gmail.com., Gunes CE; Department of Medical Biology, Faculty of Medicine, University of Konya-NE, Konya, Turkey., Vural H; Department of Medical Biology, Faculty of Medicine, University of Konya-NE, Konya, Turkey.
Source: Molecular neurobiology [Mol Neurobiol] 2025 Nov 17; Vol. 63 (1), pp. 64. Date of Electronic Publication: 2025 Nov 17.
Publication Type: Journal Article
Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first